Home » Stocks » Opiant Pharmaceuticals

Opiant Pharmaceuticals, Inc. (OPNT)

Stock Price: $9.19 USD 0.00 (0.00%)
Updated Aug 10, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 39.13M
Revenue (ttm) 38.90M
Net Income (ttm) 9.85M
Shares Out 4.26M
EPS (ttm) 1.89
PE Ratio 4.86
Forward PE 26.74
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $9.19
Previous Close $9.19
Change ($) 0.00
Change (%) 0.00%
Day's Open 9.24
Day's Range 8.85 - 9.24
Day's Volume 32,748
52-Week Range 8.05 - 18.23

More Stats

Market Cap 39.13M
Enterprise Value 9.14M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 4.26M
Float 3.06M
EPS (basic) 2.43
EPS (diluted) 1.89
FCF / Share 1.18
Dividend n/a
Dividend Yield n/a
Earnings Yield 20.57%
FCF Yield 12.84%
Payout Ratio n/a
Shares Short 11,069
Short Ratio 0.16
Short % of Float 0.23%
Beta 0.58
PE Ratio 4.86
Forward PE 26.74
P/FCF Ratio 7.79
PS Ratio 1.01
PB Ratio 1.15
Revenue 38.90M
Operating Income 9.38M
Net Income 9.85M
Free Cash Flow 5.03M
Net Cash 29.99M
Net Cash / Share 7.04
Gross Margin 60.97%
Operating Margin 24.10%
Profit Margin 25.30%
FCF Margin 12.92%
ROA 17.17%
ROE 36.24%
ROIC 188.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$40.00*
(335.26% upside)
Low
38.0
Current: $9.19
High
42.0
Target: 40.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue40.5213.9818.459.901.55-----
Revenue Growth189.8%-24.2%86.37%538.55%------
Gross Profit40.5213.9818.459.901.55-----
Operating Income10.91-21.197.09-7.74-6.90-11.30-8.81-12.34-9.44-2.02
Net Income11.59-21.206.58-7.81-7.04-11.48-9.18-12.42-9.44-2.02
Shares Outstanding4.022.992.011.911.811.751.431.040.670.87
Earnings Per Share2.17-7.102.94-4.09-3.88-6.57-6.00-12.00-14.00-2.00
Operating Cash Flow4.06-0.525.56-0.92-4.24-1.01-0.75-1.10-2.96-0.38
Capital Expenditures-0.30---0.01------
Free Cash Flow3.76-0.525.56-0.92-4.24-1.01-0.75-1.10-2.96-0.38
Cash & Equivalents30.9824.616.871.480.430.250.600.020.050.00
Total Debt0.77--0.17--0.030.22--
Net Cash / Debt30.2124.616.871.320.430.250.57-0.200.050.00
Assets40.2829.3910.811.880.490.300.640.040.080.02
Liabilities5.8612.536.476.598.873.381.630.660.420.66
Book Value34.4216.864.33-4.70-8.39-3.08-0.99-0.62-0.34-0.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Opiant Pharmaceuticals, Inc.
Country United States
Employees 21
CEO Roger Crystal

Stock Information

Ticker Symbol OPNT
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: OPNT

Description

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for opioid overdose; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.